BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15203869)

  • 1. Mu-heavy chain disease associated with systemic amyloidosis.
    Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A
    Hematology; 2004 Apr; 9(2):135-7. PubMed ID: 15203869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cast nephropathy in mu heavy chain disease.
    Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
    Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and mu-heavy chain fragment in the serum.
    Pruzanski W; Hasselback R; Katz A; Parr DM
    Am J Med; 1978 Aug; 65(2):334-41. PubMed ID: 99035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu-chain disease.
    Franklin EC
    Arch Intern Med; 1975 Jan; 135(1):71-2. PubMed ID: 1111471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heavy chain disease].
    Nomura S; Kanoh T
    Nihon Rinsho; 1995 Mar; 53(3):730-5. PubMed ID: 7699914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mu-chain disease. Report of two new cases.
    Brouet JC; Seligmann M; Danon F; Belpomme D; Fine JM
    Arch Intern Med; 1979 Jun; 139(6):672-4. PubMed ID: 109059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.
    Feremans W; Caudron M; Bieva C
    J Clin Pathol; 1979 Apr; 32(4):334-43. PubMed ID: 109474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
    Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Ohno Y
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):622-32. PubMed ID: 6814143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heavy chain diseases].
    Seligmann M
    Rev Prat; 1993 Feb; 43(3):317-20. PubMed ID: 8502962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
    Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
    Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma. A clinical review.
    Rosen BJ
    Med Clin North Am; 1975 Mar; 59(2):375-86. PubMed ID: 1078867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heavy chain deposition disease: report of a case and review of the literature].
    Imai H
    Rinsho Byori; 2001 Jul; 49(7):695-8. PubMed ID: 11519134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects.
    Jonsson V; Videbek A; Axelsen NH; Harboe M
    Scand J Haematol; 1976 Mar; 16(3):209-17. PubMed ID: 179130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-heavy chain disease: presentation as a benign monoclonal gammopathy.
    Wahner-Roedler DL; Kyle RA
    Am J Hematol; 1992 May; 40(1):56-60. PubMed ID: 1566748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gamma-1 heavy chain disease with the demonstration of Bence-Jones proteins].
    Hauke G; Krawinkel U; Schiltz E; Metz B; Hollmann A; Peter HH
    Immun Infekt; 1991 Jun; 19(3):89-90. PubMed ID: 1916871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
    Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
    Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunochemical study of serum in the diagnosis of mu-chain disease].
    Chernokhvostova EV; Batalova TN; Andreeva NE; Antipova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):42-8. PubMed ID: 404805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type K-paraproteinemia with plasma cell leukemia].
    Keller H; Spengler GA; Skvaril F; Flury W; Noseda G; Riva G
    Schweiz Med Wochenschr; 1970 Jun; 100(24):1012-22. PubMed ID: 5004028
    [No Abstract]   [Full Text] [Related]  

  • 20. Nodular glomerulosclerosis secondary to mu heavy chain deposits.
    Liapis H; Papadakis I; Nakopoulou L
    Hum Pathol; 2000 Jan; 31(1):122-5. PubMed ID: 10665924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.